Tumor Markers

Tumor markers are substances produced by tumors or other tissues in response to the presence of cancer or other abnormalities. These markers can be detected in the blood, urine or other bodily fluids, and are used to help diagnose, monitor and treat cancer. Hematology and oncology researchers study tumor markers in order to better understand how they can be used to detect and track the progression of cancer. By analyzing tumor marker levels over time, clinicians can assess the effectiveness of various treatments and make informed decisions about how to proceed with patient care. Some of the most common tumor markers used in hematology and oncology research include PSA (prostate-specific antigen), CA-125 (cancer antigen 125), and CA-19-9 (carbohydrate antigen 19-9). Each of these markers is associated with specific types of cancer or other conditions. PSA, for example, is primarily used to monitor prostate cancer, while CA-125 is used to monitor ovarian cancer. CA-19-9 is used to monitor pancreatic cancer, as well as some other gastrointestinal cancers. While tumor markers are not always 100% accurate, they can be an effective tool for detecting and monitoring cancer. By working closely with researchers in the field of hematology and oncology, medical professionals can continue to develop new diagnostic and treatment options that will help improve patient outcomes and save lives.